A practical guide to evaluation and treatment of infections in patients with central venous catheters

Journal of Intravenous Nursing

Volumn 21, Issue 5 SUPPL., 1998, Pages

  Jones, Gary R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; BLOOD CULTURE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; DIAGNOSTIC APPROACH ROUTE; HUMAN; PRACTICE GUIDELINE; REVIEW; VASCULAR ACCESS; VEIN PUNCTURE;

ALGORITHMS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CROSS INFECTION; DECISION TREES; HUMANS; INFECTION CONTROL; NURSING ASSESSMENT;

EID: 0031695553     PISSN: 08965846     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Wiener ES, McGuire P, Stolar CJ, et al. The CCSG prospective study of venous access devices: an analysis of insertions and causes for removal. J Pediatr Surg 1992;27(2):155-63.
2. van Hoff J, Berg AT, Seashore JH. The effect of right atrial catheters on infectious complications of chemotherapy in children. J Clin Oncol 1990;8:1255-62.
3. Wurzel CL, Halom K, Feldman JG, Rubin LG. Infection rates of Broviac-Hickman catheters and implantable venous devices. Am J Dis Child 1988;142:536-40.
4. Mirro J, Rao BN, Kumar M, et al. A comparison of placement techniques and complications of externalized catheters and implantable port use in children with cancer. J Pediatr Surg 1990; 25:120-4.
5. Jones GR, Konsler GK, Dunaway RP, et al. Prospective analysis of urokinase in the treatment of catheter sepsis in pediatric hematology-oncology patients. J Pediatr Surg 1993;28:350-7.
6. Christensen ML, Hancock ML, Gattuso J, et al. Patenterai nutrition associated with increased infection rate in children with cancer. Cancer 1993;72:2732-8.
7. Treston-Aurand J, Olmsted RN, Allen-Bridson K, Craig CP. Impact of dressing materials on central venous catheter infection rates. J Intraven Nurs 1997;20:201-6.
8. Reynolds MG, Tebbs SE, Elliott TS. Do dressings with increased permeability reduce the incidence of central venous catheter related sepsis? Intensive Crit Care Nurs 1997;13:26-9.
9. Decker MD, Edwards KM. Central venous catheter infections. Pediatr Clin North Am 1988;35:579-612.
10. Severien C, Nelson JD. Frequency of infections associated with implanted systems versus cuffed, tunneled Silastic venous catheters in patients with acute leukemia. Am J Dis Child 1991145:1433-8.
11. Early TF, Gregory RT, Wheeler JR, et al. Increased infection rate in double-lumen versus single-lumen Hickman catheters in cancer patients. South Med J 1990;83:34-6.
12. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993;328:1323-32.
13. Hughes WT, Armstrong D, Bodey GP, et al. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 1997;25:551-73.
14. Raucher HS, Hyatt AC, Barzilai A, et al. Quantitative blood cultures in the evaluation of septicemia in children with Broviac cultures. J Pediatr 1984;104:29-33.
15. Sherertz RJ. Heard SO, Raad II. Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonication, and flushing methodologies. J Clin Microbiol 1997;35:641-6.
16. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous catheter-related infection. N Engl J Med 1977;296:1305-9.
17. Andremont A, Paulet R, Nitenberg G, Hill C. Value of semiquantitative cultures of blood drawn through catheter hubs for estimating the risk of catheter tip colonization in cancer patients. J Clin Microbiol 1988;26:2297-9.
18. Benezra D, Kiehn TE, Gold JWM, et al. Prospective study of infections in indwelling central venous catheters using quantitative blood cultures. Am J Med 1988;85:495-8.
19. Flynn PM, Shenep JL, Stokes DC, Barrett FF. In situ management of confirmed central venous catheter-related bacteremia. Pediatr Infect Dis J 1987;6:729-34.
20. Dato VM, Dajani AS. Candidemia in children with central venous catheters: role of catheter removal and amphotericin-B therapy. Pediatr Infect Dis J 1990;9:309-14.
21. Dugdale DC, Ramsey PG. Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med 1990;89:137-41.
22. Karmochkine M, Brunet F, Lanore JJ, et al. Recovery from staphylococcal septicaemia in neutropenic patients without removal of the previously inserted central venous catheter. Eur J Med 1993;2: 143-7.
23. Herrmann M, Vaudaux PE, Pittet D, et al. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988;158:693-701.
24. Cheung AL, Fischetti VA. The role of fibrinogen in mediating staphylococcal adherence to fibers. J Surg Res 1991;50:150-5.
25. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol 1995;49: 711-45.
26. Raad II, Luma M, Khalil SM, et al. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994;271:1014-16.
27. Hurtubise MR, Bottino JC, Lawson M, McCredie KB. Restoring patency of occluded central venous catheters. Arch Surg 1980;115: 212-3.
28. Glynn MF, Langer B, Jeejeebhoy KN. Therapy for thrombotic occlusion of long-term intravenous alimentation catheters. J Parenter Enter Nutr 1980;4:387-90.
29. Lewis JA, LaFrance R, Bower RH. Treatment of an infected silicone right atrial catheter with combined fibrinolytic and antibiotic therapy: case report and review of the literature. J Parenter Enter Nutr 1989;13:92-8.
30. Fishbein JD, Friedman HS, Bennett BB, et al. Catheter-related sepsis refractory to antibiotics treated successfully with adjunctive urokinase infusion. Pediatr Infect Dis J 1990;9:676-8.
31. Ascher DP, Shoupe BA, Maybee D, Fischer GW. Persistent catheter-related bacteremia: clearance with antibiotics and urokinase. J Pediatr Surg 1993;28:627-9.
32. Jones GR, Konsler GK, Dunaway RP. Urokinase in the treatment of bacteremia and candidemia in patients with right atrial catheters. Am J Infect Control 1996;24:160-6.
33. Flynn PM, van Hooser B, Gigliotti F. Atypical mycobacterial infections of Hickman catheter exit sites. Pediatr Infect Dis J 1991;8: 510-13.
34. Flowers RH, Schwenzer KJ, Kopel RF, et al. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection: a randomized, controlled trial. JAMA 1989;216: 878.
35. Barnes JR, Lucas N, Broadwater JR, Hauer-Jensen M. When should the "infected" subcutaneous infusion reservoir be removed? Am Surgeon, 1996;62:203-6.
36. US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention. Guideline for prevention of intravascular device-related infections. Am J Infect Control 1996;24:262-93.
37. Johnson DC, Johnson FL, Goldman S. Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients. Pediatr Infect Dis J 1994;13:930-1
38. Krzywda EA, Andris DA, Edminston CE Jr., Quebbeman EJ. Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect Control Hosp Epidemiol 1995;16:596-8.
39. Rackoff WR, Weiman M, Jakobowski D, et al. A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. J Pediatr 1995;127:147-51.
40. Raad II, Hachem RY, Abi-Said D, et al. A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2. Cancer 1998;82:403-11.
41. Fraschini G, Becker M, Bruso P, et al. Comparative trial of urokinase vs heparin as prophylaxis for central venous ports. Proc Am Soc Clin Oncol 1991;10:337.
42. Bagnall-Reeb H, Saltzman DA, Smith CM, Leonard AS. Prophylactic scheduled urokinase for the prevention of right atrial catheter infection. Oncol Nurs Forum 1993;20:315.
43. Williams I, Venables WA, Lloyd D, et al. The effects of adherence to silicone surfaces on antibiotic susceptibility in Staphylococcus aureus. Microbiology 1997;143:2407-13.
44. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med 1997;127:257-66.
45. Raad II, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann Intern Med 1997;127:267-74.
46. Ciresi DL, Albrecht RM, Volkers PA, Scholten DJ. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surgeon 1996;62:641-6.
47. Groeger JS, Lucas AB, Coit D, et al. A prospective, randomized evaluation of the effect of silver-impregnated subcutaneous cuffs for preventing tunneled chronic venous access catheter infections in cancer patients. Ann Surg 1993;218:206-10.
48. Segura M, Alvarez-Lerma F, Tellado JM, et al. Advances in surgical technique: a clinical trial on the prevention of catheter-related sepsis using new hub model. Ann Surg 1996;223:363-9.